The CONFORM Pivotal Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 1600 participants.

Also called NCT05147792

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 1,600 participants (planned count) (from the registry)
Sponsor
Conformal Medical, Inc (from the registry)
Registry
  • NCT NCT05147792
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Czechia, France, Georgia, Germany, Uzbekistan (from the registry)
Registry status
  • Suspended (from the registry)

Technical summary

Registry record NCT05147792. Randomized; no masking; primary purpose prevention. Start 2022-05-26 (actual); primary completion 2028-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The CONFORM Pivotal Trial
Condition
Stroke
Intervention (Device)
CLAAS
Intervention (Device)
WATCHMAN left atrial appendage closure device / Amulet left atrial appendage occluder
Lead sponsor
Conformal Medical, Inc (class: industry)

Record details

Record id
cardio:ct-nct05147792
Content hash
4456d3ee4ea2c5707b5c8336d01ca4fd1778e6f24cf59ebf4619a99c023ae666